How Britain's Libel Laws Nearly Destroyed Free Speech | Baroness Claire Fox (#45)
Baroness Claire Fox argues that the culture of competitive victimhood that shuts down free speech is the same force enabling the unchecked medicalisation of gender-dysphoric youth. For European audiences watching Sweden and the Netherlands reverse course on gender medicine, her diagnosis of how therapeutic culture paralysed adult judgment carries particular weight. The conversation ties legal intimidation, safetyism and children's welfare into a single urgent argument.
Baroness Claire Fox of Buckley carries one of the more unusual political biographies in British public life. A former member of the Revolutionary Communist Party who went on to found the Academy of Ideas and eventually join the House of Lords as a non-affiliated peer, she has spent decades defending the kind of open, adversarial debate that progressive movements once claimed as their own. That history gives her a distinctive vantage point on how the left can turn against freedom — and why its doing so has left children exposed. At the heart of this conversation is a legal episode little discussed outside the United Kingdom. The Living Marxism libel case of the 1990s, in which a small political magazine was sued into closure by a broadcaster over its reporting on the Bosnian conflict, illustrated how defamation law can be deployed not to correct falsehoods but to erase uncomfortable voices. European listeners will recognise the pattern immediately: across the continent, criminal defamation statutes, hate-speech codes, and the quiet threat of professional sanction have long performed the same function, discouraging dissent before it ever reaches public view. Fox's deeper argument concerns the cultural shift that made such silencing feel not just tolerable but righteous. Competitive victimhood — the practice of treating the most aggrieved voice as automatically authoritative — gave the phrase "I find that offensive" the force of a veto. That logic did not stay in seminar rooms. It moved into clinical settings, schools and the institutions designed to protect children. When a young person frames their gender identity as a survival issue and any questioning as an act of violence, the same mechanism operates: to hesitate is to harm. The European dimension makes Fox's diagnosis particularly pressing. The Netherlands developed the puberty-blocker protocol that spread across the world; Sweden and Finland have since curtailed gender medicine for minors after systematic evidence reviews found the benefit-risk balance unsatisfactory. In both countries, restriction required professionals and policy-makers to say no inside a culture that had recast clinical caution as ideological cruelty. Germany's recent self-identification legislation and the EU's continued institutional promotion of gender-identity frameworks suggest that the pressures Fox describes are not a British peculiarity but a continental condition. Fox draws a further line to the assisted suicide debate, where she sees the same capitulation to therapeutic language: institutions so saturated with the vocabulary of individual autonomy and unbearable pain that they lose the capacity to refuse demands that may cause grave harm. Her argument is not that young people's distress is imaginary but that adults who genuinely care must be willing to hold a boundary even when it is emotionally costly to do so. That case will resonate with the European clinicians, parents and policymakers who have already begun to push back — and with those still looking for the words to start.
